NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE
1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature
of Operations and Organization
Indoor
Harvest Corp (the “Company,”) is a Texas corporation formed on November 23, 2011. Our principal executive office was located
at 7401 W. Slaughter Lane #5078, Austin, Texas 78739, and such address is used in the interim. We are in the process
of establishing new offices.
On
August 14, 2019, the Company established a wholly owned subsidiary, IHC Consulting, Inc. (“IHC”), in the State of New York
of the United States of America. IHC Consulting will provide consulting and other services to the Company and others on a contracted
basis.
COVID-19
A
novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World
Health Organization on March 11, 2020. As a result of the outbreak, many companies have experienced disruptions in their operations and
in markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the
well-being of its managers and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates
used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at
September 30, 2020. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak
could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of
the Company to develop its business plan.
Interim
Financial Statements
The
accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles (GAAP) applicable
to interim financial information and the requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the Securities and Exchange Commission.
Accordingly, they may not include all of the information and disclosure required by accounting principles generally accepted in the United
States of America for complete financial statements. Interim results are not necessarily indicative of results for a full year. In the
opinion of management, all adjustments considered necessary for a fair presentation of the financial position and the results of operations
and cash flows for the interim periods have been included. These interim financial statements should be read in conjunction with the
audited financial statements for the year ended December 31, 2020, as not all disclosures required by generally accepted accounting principles
for annual financial statements may be presented. The interim financial statements follow the same accounting policies and methods of
computations as the audited financial statements for the year ended December 31, 2020.
Basis
of Presentation
The
accompanying condensed consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting
principles generally accepted in the United States of America (“GAAP”) and the requirements of Form 10-Q and Rule 8-03 of
Regulation S-X of the U.S. Securities and Exchange Commission. Accordingly, they may not include all of the information and disclosures
required by accounting principles generally accepted in the United States of America for complete financial statements. Interim results
are not necessarily indicative of results for a full year. In the opinion of management, all adjustments considered necessary for a fair
presentation of the financial position and the results of operations and cash flows for the interim periods have been included. These
interim financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2020,
as not all disclosures required by generally accepted accounting principles for annual financial statements may be presented.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Significant
estimates include, but are not limited to, the estimate of percentage of completion on construction contracts in progress at each reporting
period which we rely on as a primary basis of revenue recognition, estimated useful lives of equipment for purposes of depreciation and
the valuation of common shares issued for services, equipment and the liquidation of liabilities.
Principles
of Consolidation
The
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant inter-company
accounts and transactions have been eliminated in consolidation.
Earnings
(Loss) per Share
Basic
earnings (loss) per share amounts are calculated based on the weighted average number of shares of common stock outstanding during each
period. Diluted earnings (loss) per share is based on the weighted average numbers of shares of common stock outstanding for the periods,
including dilutive effects of stock options, warrants granted and convertible preferred stock. Dilutive options and warrants that are
issued during a period or that expire or are cancelled during a period are reflected in the computations for the time they were outstanding
during the periods being reported. Since Indoor Harvest has incurred losses for all periods, the impact of the common stock equivalents
would be anti- dilutive and therefore are not included in the calculation.
Derivative
Liability
The
Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative
instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and
requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting
for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types
of relationships designated are based on the exposures hedged. At September 30, 2021 and December 31, 2020, the Company did not have
any derivative instruments that were designated as hedges.
Fair
Value of Financial Instruments
As
defined in ASC 820” Fair Value Measurements,” fair value is the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes
market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and
the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally
unobservable. The Company classifies fair value balances based on the observability of those inputs. ASC 820 establishes a fair value
hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices
in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
The
following table summarizes fair value measurements by level at September 30, 2021 and December 31, 2020, measured at fair value on a
recurring basis:
SCHEDULE OF FAIR VALUE OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS
September 30, 2021
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
420,313
|
|
|
$
|
420,313
|
|
December 31, 2020
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
44,274,727
|
|
|
$
|
44,274,727
|
|
Recently
Issued Accounting Pronouncements
In
August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with “Conversion and Other Options”
and ASC subtopic 815-40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting
models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation
models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition
of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued
with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal
years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier
than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently assessing
the impact of the adoption of this standard on its consolidated financial statements.
NOTE
2 - GOING CONCERN
The
accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. The Company had minimal
cash as of September 30, 2021, incurred losses from its operations and did not generate cash from its operation for past two years and
the nine months ended September 30, 2021. These factors, among others, raise substantial doubt about the Company’s ability to continue
as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The
Company’s continued existence is dependent upon management’s ability to develop profitable operations, continued contributions
from the Company’s executive officers to finance its operations and the ability to obtain additional funding sources to explore
potential strategic relationships and to provide capital and other resources for the further development and marketing of the Company’s
products and business.
NOTE
3 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts
payable and accrued liabilities at September 30, 2021 and December 31, 2020 are as follows:
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Accounts payable
|
|
$
|
248,649
|
|
|
$
|
283,357
|
|
Credit card
|
|
|
13,645
|
|
|
|
16,570
|
|
Accrued expenses
|
|
|
15,715
|
|
|
|
15,714
|
|
Accrued management fee
|
|
|
3,183
|
|
|
|
3,605
|
|
Accrued interest
|
|
|
1,362
|
|
|
|
35,350
|
|
Accounts payable and
accrued liabilities
|
|
$
|
282,554
|
|
|
$
|
354,596
|
|
NOTE
4 - CONVERTIBLE NOTES PAYABLE
Convertible
notes payable at September 30, 2021 and December 31, 2020 are as follows:
SCHEDULE OF CONVERTIBLE NOTES PAYABLE
|
|
September 30,
|
|
|
December 31,
|
|
|
|
2021
|
|
|
2020
|
|
Note 1
|
|
$
|
-
|
|
|
$
|
50,000
|
|
Note 2
|
|
|
-
|
|
|
|
25,200
|
|
Note 3
|
|
|
-
|
|
|
|
38,000
|
|
Note 4 - related party
|
|
|
10,000
|
|
|
|
10,000
|
|
Note 5
|
|
|
25,000
|
|
|
|
-
|
|
Total convertible notes payable
|
|
|
35,000
|
|
|
|
123,200
|
|
|
|
|
|
|
|
|
|
|
Less: Unamortized debt discount
|
|
|
(10,556
|
)
|
|
|
-
|
|
Total convertible notes
|
|
|
24,444
|
|
|
|
123,200
|
|
|
|
|
|
|
|
|
|
|
Less: current portion of convertible notes
|
|
|
24,444
|
|
|
|
123,200
|
|
Long-term convertible notes
|
|
$
|
-
|
|
|
$
|
-
|
|
During
the nine months ended September 30, 2021 and 2020, the Company recorded interest expense of $31,720 and $492,162, and amortization of
discount of $14,444 and $111,685, respectively. As of September 30, 2021 and December 31, 2020, the Company had accrued interest of $1,362
and $35,350, respectively.
Repayment
The
Company had a dispute with Power Up, the holder of certain promissory notes dated October 22, 2019, and December 19, 2019, issued by
the Registrant, including allegations or claims of default and a suit. As part of the Company’s recovery efforts after COVID-19,
it reached an amicable resolution with “Power Up”, in third quarter of 2021, whereby the Company and Power Up agreed on an
amount of $80,000 to settlement this dispute in its entirety. During nine months ended September 30, 2021, the Company repaid $80,000
to Power Up for Note 2 and 3 and accrued interest. As a result, the Company recorded loss on settlement of debt of $4,987.
Note
1
On
October 12, 2017, the Company issued a fixed convertible promissory note to Tangiers for the principal sum of $50,000 as a commitment
fee for the Investment Agreement. The promissory note (“Note 1”) maturity date is May 12, 2018. The principal amount due
under Note 1 can be converted by Tangiers any time, into shares of the Company’s common stock at a conversion price of $0.1666
per share. The promissory note is in a “Maturity Default,” which is defined in Note 1 as the event in which Note 1 is not
retired prior to its maturity date, Tangiers’ conversion rights under Note 1 would be adjusted such that the conversion price would
be the lower of (i) $0.1666 or (ii) b) 65% of the average of the two lowest trading prices of the Company’s common stock during
the 10 consecutive trading days prior to the date on which Tangiers elects to convert all or part of the note. The default interest rate
is 20%. During nine months ended September 30, 2021, the note was fully forgiven and the Company recorded gain on settlement of debt
of $89,451.
Note
2
On
October 22, 2019, the Company issued and sold an 10% Fixed Convertible Promissory Note (“Note 2”) to Power Up Lending Group
Ltd. (“Power Up”), in the principal amount of $48,000, which includes a $3,000 original issue discount. Note 2 is convertible
into shares of the Company’s common stock one hundred eighty (180) days from October 22, 2019. Note 2 is convertible at a conversion
price of 61% of the average of the two (2) lowest trading prices of the Company’s common stock during the twenty (20) consecutive
trading days prior to the date of on which Power Up elects to convert all or part of the Note 2.
Note
3
On
December 19, 2019, the Company issued and sold an 10% Fixed Convertible Promissory Note (“Note 3”) to Power Up Lending Group
Ltd. (“Power Up”), in the principal amount of $38,000, which includes a $3,000 original issue discount. Note 3 is convertible
into shares of the Company’s common stock one hundred eighty (180) days from December 22, 2019. Note 3 is convertible at a conversion
price of 61% of the average of the two (2) lowest trading prices of the Company’s common stock during the twenty (20) consecutive
trading days prior to the date of on which Power Up elects to convert all or part of the Note 3.
Note
4 – related party
On
September 28, 2020, the Company issued and sold an 10% Fixed Convertible Promissory Note (“Note 4”) to a related party, in
the principal amount of $10,000. Note 4 is convertible into shares of the Company’s common stock ninety (90) days from September
28, 2020. Note 4 is convertible at the lower conversion price of $0.002 or 65% of the lowest trading prices of the Company’s common
stock during the fifteen (15) consecutive trading days prior to the date of on which a noteholder elects to convert all or part of the
Note 4. The note is currently in default.
Note
5
In
March 2021, a third party advanced $25,000 to assist the Company in operating expenses and the Company is in the process of confirming
arrangements for the repayment of said amount. The advance has non-interest bearing.
On
August 9, 2021, the Company issued and sold an 10% Fixed Convertible Promissory Note (“Note 5”), in the principal amount
of $25,000. Note 5 is convertible into shares of the Company’s common stock sixty (60) days from August 9, 2021. Note 5 is convertible
at the lower conversion price of $0.00225 or 65% of the lowest trading prices of the Company’s common stock during the fifteen
(15) consecutive trading days prior to the date of on which a noteholder elects to convert all or part of the Note 5.
NOTE
5 - DERIVATIVE LIABILITIES
The
Company identified the conversion features embedded within its convertible debts as financial derivatives. The Company has determined
that the embedded conversion option should be accounted for at fair value.
At
September 30, 2021, the estimated fair values of the liabilities measured on a recurring basis are as follows:
SCHEDULE
OF ESTIMATED FAIR VALUE OF LIABILITIES MEASURED ON RECURRING BASIS
|
|
Nine months ended
|
|
|
|
September 30, 2021
|
|
Expected term
|
|
|
0.10 - 0.25
|
|
Expected average volatility
|
|
|
165% - 191
|
%
|
Expected dividend yield
|
|
|
-
|
|
Risk-free interest rate
|
|
|
0.07
|
%
|
The
following schedule shows the change in fair value of the derivative liabilities at September 30, 2021:
SCHEDULE OF CHANGE IN FAIR VALUE OF DERIVATIVE LIABILITIES
Fair Value Measurements Using Significant Observable Inputs (Level 3)
|
Balance - December 31, 2020
|
|
$
|
44,274,727
|
|
Addition of new derivatives recognized as debt discounts
|
|
|
25,000
|
|
Addition of new derivatives recognized as loss on derivatives
|
|
|
96,923
|
|
Loss on change in fair value of the derivative
|
|
|
(43,976,337
|
)
|
Balance - September 30, 2021
|
|
$
|
420,313
|
|
The
aggregate (gain) loss on derivatives during the nine months ended September 30, 2021 and 2020 was ($43,976,337) and $23,849,072, respectively.
The Company values these derivative liabilities using Black-Scholes model or flexible the pricing models that include quantitative input
such as the risk free rate, market volatility, time to maturity, conversion price, and other qualitative factors such as whether the
underlying indexed security is in good standing or in default.
NOTE
6 - SHAREHOLDERS’ EQUITY
Series
A Convertible Preferred Stock
As
of September 30, 2021 and December 31, 2020, there were 750,000 shares of Series A Convertible Preferred Stock issued and outstanding.
On
August 27, 2021, the Company completed an initiative where it entered into a Modification Agreement (the “Modification”)
with current Series A Convertible Preferred Stockholders to modify their conversion privileges to align and support the current management
team’s initiatives with the goal of benefiting shareholders. The modification agreement provides the preferred stockholders the
right to convert their preferred shares into common shares at a conversion price at the lower of $0.40 (per the original agreement),
or the subsequent per share pricing of a future equity raise greater than Five Hundred Thousand ($500,000) Dollars. This Modification
was pursued for the benefit of the Company’s common shareholders to mitigate the potential risk of diluting their shareholding
in the event that the Company undertakes additional financing transactions to fund the Company’s expansion initiatives.
Common
Stock
During
the nine months ended September 30, 2021, there were no share issuances.
On
August 26, 2021, the Company entered into subscription agreements, with certain accredited investors for the sale of 82,000,000 shares
of the Company’s common stock, par value of $0.001 per share, for a total consideration to the Company of $410,000.
As
of September 30, 2021 and December 31, 2020, there were 2,483,396,041 and 2,401,396,041 shares of Common Stock issued and outstanding.
Additional
paid in capital
During
the nine months ended September 30, 2021, the amount due to related party of $52 was forgiven and the Company recorded additional paid
in capital.
Stock
Options
On
August 4, 2021, the Board has recognized the substantive efforts of Messrs. Leslie Bocskor, Benjamin Rote, and Dennis Forchic to sustain
and support the Company over the past year without compensation while laying the foundation for the future. The Board has voted to formalize
employment agreements with Messrs. Bocskor and Rote, and an advisory agreement with Mr. Forchic. Stock option agreements reflecting past
contributions and incentives for the future have been issued to all three parties. Stock options plans were offered with an exercise
price of $0.01 and
consideration of 150
million options to Mr. Bocskor, 100
million options to Mr. Rote, and 150
million options to Mr. Forchic vesting immediately.
On the 1-year anniversary of their respective agreements, additional stock options priced at $0.015
will vest with consideration of 150
million options to Mr. Bocskor, 100
million options to Mr. Rote, and 150
million options to Mr. Forchic.
In
addition, the Board, consisting of Directors Rick Gutshall and Lang Coleman, having not received any consideration over the past 2 years,
will receive stock options of 5 million options each at a price of $0.01 vesting immediately. The company’s legal counsel will
be receiving 10 million options at a price of $0.01 vesting immediately, under the same terms as the Board, in recognition of their valuable
work and support.
Valuation
The
Company utilizes the Black-Scholes model to value its stock options. The Company utilized the following assumptions:
SCHEDULE OF UTILIZES THE BLACK-SCHOLES MODEL TO VALUES TO STOCK OPTIONS ASSUMPTIONS
|
|
Nine months ended
|
|
|
|
September 30, 2021
|
|
Expected term
|
|
|
5.00 - 5.50 years
|
|
Expected average volatility
|
|
|
198 - 203
|
%
|
Expected dividend yield
|
|
|
-
|
|
Risk-free interest rate
|
|
|
0.67
|
%
|
During
the nine months ended September 30, 2021, the Company granted 820,000,000 options valued at $8,004,855. During the nine months ended
September 30, 2021, the Company recognized stock option expense of $4,753,205, of which $4,655,518 was to related parties, and as of
September 30, 2021, $2,763,902 remains unamortized, of which $2,763,902 is with related parties. The intrinsic value of the 820,000,000
options outstanding as of September 30, 2021 is $9,398,000.
The
following is a summary of stock option activity during the nine months ended September 30, 2021:
SCHEDULE
OF STOCK OPTION
|
|
Options Outstanding
|
|
|
Weighted
|
|
|
|
Number of
|
|
|
Weighted
Average
|
|
|
Average
Remaining life
|
|
|
|
Options
|
|
|
Exercise Price
|
|
|
(years)
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2020
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
Granted
|
|
|
820,000,000
|
|
|
|
0.01
|
|
|
|
10.00
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Forfeited/canceled
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding, September 30, 2021
|
|
|
820,000,000
|
|
|
$
|
0.01
|
|
|
|
9.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable options, September 30, 2021
|
|
|
420,000,000
|
|
|
$
|
0.01
|
|
|
|
9.85
|
|
NOTE
7 - NET INCOME (LOSS) PER COMMON SHARE
Basic
net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the
periods. Diluted net income per common share is computed using the weighted average number of common and dilutive common equivalent shares
outstanding during the periods. Common equivalent shares consist of convertible preferred stock and convertible notes that are computed
using the if-converted method, and outstanding warrants that are computed using the treasury stock method. Antidilutive stock awards
consist of stock options that would have been antidilutive in the application of the treasury stock method.
SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
116,422,813
|
|
|
$
|
25,444,732
|
|
|
$
|
39,052,316
|
|
|
$
|
(24,533,172
|
)
|
(Gain) on change in fair value of derivatives
|
|
|
(121,194,219
|
)
|
|
|
(25,835,130
|
)
|
|
|
(43,879,414
|
)
|
|
|
-
|
|
Interest on convertible debt
|
|
|
608
|
|
|
|
329,453
|
|
|
|
1,104
|
|
|
|
-
|
|
Net income (loss) - diluted
|
|
$
|
(4,770,798
|
)
|
|
$
|
(60,945
|
)
|
|
$
|
(4,825,994
|
)
|
|
$
|
(24,533,172
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
|
|
|
2,433,482,998
|
|
|
|
818,037,754
|
|
|
|
2,412,209,228
|
|
|
|
513,135,724
|
|
Effect of dilutive shares
|
|
|
207,748,451
|
|
|
|
12,939,919,067
|
|
|
|
643,116,261
|
|
|
|
-
|
|
Diluted
|
|
|
2,641,231,449
|
|
|
|
13,757,956,821
|
|
|
|
3,055,325,489
|
|
|
|
513,135,724
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.05
|
|
|
$
|
0.03
|
|
|
$
|
0.02
|
|
|
$
|
(0.05
|
)
|
Diluted
|
|
$
|
(0.00
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.05
|
)
|
For
the nine months ended September 30, 2020, the convertible instruments are anti-dilutive and therefore, have been excluded from earnings
(loss) per share.
NOTE
8 - SUBSEQUENT EVENTS
The
Company evaluates subsequent events that have occurred after the balance sheet date of September 30, 2021, and up through November 15,
2021, which is the date that these financial statements are available to be issued. There are two types of subsequent events: (i)
recognized, or those that provide additional evidence with respect to conditions that existed at the date of the balance sheet, including
the estimates inherent in the process of preparing financial statements, and (ii) non-recognized, or those that provide evidence with
respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date.
On
October 1, the Company converted the Electrum Partners outstanding Convertible Promissory Note of $10,000 issued
September 28, 2021 into 5,125,000 restricted
common shares of the Company.
On
November 8, 2021, the Company finalized a Supplemental agreement with the Series A Preferred shareholders to convert their holdings
into common shares of the Company at $0.0125
in alignment and support of the current management
team’s initiatives with the goal of benefiting shareholders. This agreement was pursued for the benefit of the Company’s
common shareholders to mitigate the potential risk of diluting their shareholding in the event that the Company undertakes additional
financing transactions to fund the Company’s expansion initiatives.
Pursuant to the Preferred Shareholder’s
Supplemental Agreement dated November 8, 2021 (the “Supplemental Agreement”) by and between the Company and holders of its
Series A Preferred shares, under which holders of the Series A Preferred shares agreed to convert all of the Series A Preferred shares
into common shares of the Company effective November 8, 2021, the Company has issued an aggregate of sixty (60) million restricted common
shares. The restricted common shares issued are subject to Rule 144 required holding periods.
On
November 8, 2021, the Company entered into subscription agreements with certain accredited investors for the sale of Sixteen Million
(16,000,000) common shares of the Company, par value of $0.001 per share, for a total consideration to the Company of Two Hundred Thousand
($200,000) Dollars. The issued shares will be restricted under Rule 144 required holding periods. The Company intends to use the net
proceeds from the sale for general corporate purposes and working capital.
On
November 9, the Company converted the $25,000 10% Fixed Convertible Promissory Note, including interest, issued on August 9, 2021
into 11,388,889 common shares. The issued shares will be restricted under Rule 144 required holding periods.